新疆乌苏市市场监管局召开药品经营环节“清源”行动推进会

Core Viewpoint - The Urumqi Market Supervision Administration is intensifying efforts to regulate the pharmaceutical distribution sector through a "Clean Source" initiative aimed at addressing prominent issues in drug sales and ensuring drug quality safety [1][3][4] Group 1: Regulatory Actions - The administration has mobilized 127 pharmaceutical companies to adhere to principles of "strict prevention at the source, strict management during the process, and strict risk control" [3] - Key focuses include combating illegal drug sales, counterfeit drugs, and violations in online drug sales [3] - Specific measures include enhanced online inspections, strict checks on illegal procurement channels, and increased oversight of high-risk drugs [3] Group 2: Compliance and Training - The administration emphasizes the importance of compliance by requiring pharmaceutical companies to implement full product traceability and rectify identified issues [3][4] - Future plans include ongoing training for pharmacy staff to ensure comprehensive understanding of regulations, thereby safeguarding public health [4]